Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal.

MLA

Holm, Frida, et al. “Reversion to an Embryonic Alternative Splicing Program Enhances Leukemia Stem Cell Self-Renewal.” Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 50, Dec. 2015, pp. 15444–49. EBSCOhost, https://doi.org/10.1073/pnas.1506943112.

APA

Holm, F., Hellqvist, E., Mason, C. N., Ali, S. A., Delos-Santos, N., Barrett, C. L., Chun, H.-J., Minden, M. D., Moore, R. A., Marra, M. A., Runza, V., Frazer, K. A., Sadarangani, A., & Jamieson, C. H. M. (2015). Reversion to an embryonic alternative splicing program enhances leukemia stem cell self-renewal. Proceedings of the National Academy of Sciences of the United States of America, 112(50), 15444–15449. https://doi.org/10.1073/pnas.1506943112

Chicago

Holm, Frida, Eva Hellqvist, Cayla N. Mason, Shawn A. Ali, Nathaniel Delos-Santos, Christian L. Barrett, Hye-Jung Chun, et al. 2015. “Reversion to an Embryonic Alternative Splicing Program Enhances Leukemia Stem Cell Self-Renewal.” Proceedings of the National Academy of Sciences of the United States of America 112 (50): 15444–49. doi:10.1073/pnas.1506943112.